EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Knowing the level of oxygen in tumor tissue may help predict the effectiveness of
anticancer therapy. EF5 may be effective in measuring oxygen in tumor tissue and helping to
predict the effectiveness of anticancer therapy.
PURPOSE: Diagnostic trial to study the effectiveness of EF5 in detecting tumor hypoxia in
patients who have stage IIB, stage IIIB, or stage IVA cervical cancer.